Accelerating Huntington's Disease Research And Drug Development Using Digital Health Technologies

This webinar is designed for clinical trial leaders, neurologists, digital health innovators, and translational researchers seeking more effective ways to measure disease progression in Huntington’s Disease (HD). Experts from academia, industry, and nonprofit research organizations explore how digital health technologies (DHTs), wearable sensors, and smartphone-based assessments can capture real-world motor and non-motor symptoms that traditional endpoints often miss. Attendees will gain insight into the HD-Integrated Staging System (HD-ISS), patient stratification strategies, and the growing role of passive, longitudinal monitoring in early-stage HD trials. The session also addresses practical considerations for deploying DHTs in clinical research, including patient usability, adherence, data interpretation, and evidence generation to support next-generation digital movement measures.